Orgenesis Inc. Note Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Convertible Note convertible into Units or Hemogenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Promissory Note, dated as of November 4, 2024, by and between Orgenesis Maryland LLC, the Company and Jacob Safier
Note Agreements
Orgenesis Inc.
2024
Amended and Restated Promissory Note, dated as of August 23, 2024, by and between Orgenesis Maryland LLC, Jacob Safier and Orgenesis Inc
Note Agreements
Orgenesis Inc.
2024
Convertible Loans and Unsecured Convertible Notes Extension #2 Agreement, dated as of January 12, 2023, by and between the Company and Yehuda Nir
Note Agreements
Orgenesis Inc.
Biotechnology
2023
Convertible Note Extension Agreement, dated July 15, 2022, by and among the Company and J. Ezra Merkin
Note Agreements
Orgenesis Inc.
Biotechnology
2022
Unsecured Convertible Note Extension Agreement, dated as of September 13, 2021, between the Company and Yehuda Nir
Note Agreements
Orgenesis Inc.
Biotechnology
NV
2021
Form of Convertible Note convertible into Units,by and between the Company and Investors
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2019
Form of Convertible Note convertible into Units or Immungenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Form of Convertible Note convertible into Units or Hemogenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Form of Convertible Note convertible into Units or Immungenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Form of Convertible Note convertible into Units or Hemogenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Form of Convertible Note convertible into Units or Immugenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Form of Convertible Note convertible into Units or Hemogenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018
Form of Convertible Note convertible into Units or Immungenyx Securities
Note Agreements
Orgenesis Inc.
Biotechnology
NY
2018